News Sentiment

CGEN sentiment intelligence

Compugen news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors Options RSS feed
Weighted score 51 Balanced news tone 66 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.41 Week of 7 Aug 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Earnings

77/100 classification confidence.

Company focus 57

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

+2.6% over one week, +0.8% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Compugen: Better Runway Ahead Of MAIA

Market Reaction

Balanced read

58/100 confidence

News tone and price action are not far from neutral.

Primary event Earnings 77/100 classification
One-week reaction 2.6% Price confirming higher
Trend fit Trend active 0.8% over four weeks
Fair value 34.9% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 47
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 57
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 14
Market source 11
TradingKey 6
Moomoo 3
TradingView 3
PR Newswire 3
Seeking Alpha 2
GuruFocus.com 2

Event Lens

What the news is about

Classified themes
Earnings 33
Market update 26
Analyst action 4
Balance sheet 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 66
Investing.com Nigeria Direct company coverage

Form 4 COMPUGEN LTD For: 30 July By Investing.com

This article reports on a Form 4 filing for COMPUGEN LTD on July 30, 2026. Form 4 filings are legally required documents filed with the SEC whenever there is a material change in the holdings of company insiders. The article provides a brief overview of the filing, referencing Re

Tone
Neutral 50/100
Event
Market update
Published
30 Jul 2026 20:40
Source
Investing.com Nigeria
Stock Titan Direct company coverage

Compugen (CGEN) awards options and RSUs to board director

Compugen Ltd. (CGEN) director Mathias Hukkelhoven was granted equity awards on July 29, 2026. The awards include options for 10,000 Ordinary Shares with a $2.26 exercise price and an RSU award for 7,500 shares. Both awards are subject to vesting schedules tied to his continued se

Tone
Neutral 50/100
Event
Market update
Published
30 Jul 2026 20:39
Source
Stock Titan
Stock Titan Direct company coverage

COMPUGEN LTD (CGEN) grants 24,000 share options and 18,000 RSUs to SVP

COMPUGEN LTD (CGEN) has granted SVP of Business Development, Zurit Levine, 18,000 restricted stock units (RSUs) and 24,000 share options with an exercise price of $2.26 per share. Both awards have an initial vesting of 25% on September 30, 2027, with the remainder vesting in 12 e

Tone
Neutral 50/100
Event
Market update
Published
30 Jul 2026 20:39
Source
Stock Titan
Stock Titan Direct company coverage

Compugen Ltd (CGEN) awards COO Pierre Ferre 70,000 stock options

Compugen Ltd (CGEN) has awarded its Chief Operating Officer, Pierre Ferre, 70,000 share options at an exercise price of $4.00 per share. These options are set to expire on July 29, 2036, with a vesting schedule that grants 25% on September 30, 2027, and the remainder in 12 equal

Tone
Neutral 50/100
Event
Market update
Published
30 Jul 2026 19:39
Source
Stock Titan
Stock Titan Direct company coverage

Compugen Ltd (CGEN) grants RSUs and stock options to senior executive

Compugen Ltd (CGEN) has awarded SVP of Research & Discovery, Kredo Russo Sharon, with 18,000 restricted stock units and options for 24,000 ordinary shares at an exercise price of $2.26. Both awards were granted on July 29, 2026, and are subject to a vesting schedule, with 25% ves

Tone
Neutral 50/100
Event
Market update
Published
30 Jul 2026 19:39
Source
Stock Titan
Stock Titan Direct company coverage

Compugen Ltd (CGEN) grants RSUs and options to board director

Compugen Ltd (CGEN) board director Sanford S. Zweifach received 7,500 restricted stock units (RSUs) and an option for 10,000 ordinary shares with an exercise price of $2.26 on July 29, 2026. Both awards vest 25% on October 1, 2027, with the remainder vesting in 12 equal quarterly

Tone
Neutral 50/100
Event
Market update
Published
30 Jul 2026 19:39
Source
Stock Titan
TradingKey Direct company coverage

Compugen Ltd (CGEN) Institutional Confidence

Compugen Ltd (CGEN) has an institutional shareholding score of 3.00, ranking it 191 out of 384 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion stands at 14.54%, showing a 16.20% decrease quarter-over-quarter. James Simons is the

Tone
Neutral 50/100
Event
Market update
Published
30 Jul 2026 03:34
Source
TradingKey
TradingKey Direct company coverage

Compugen Ltd (CGEN) Financial Health: Profitability & Balance Sheet Analysis

Compugen Ltd (CGEN) has a financial score of 6.25, ranking 274 out of 384 in the Biotechnology & Medical Research industry, indicating robust financial status but low operating efficiency. The company reported a quarterly revenue of $2.18M, with year-over-year decreases of 4.73%

Tone
Negative 39/100
Event
Earnings
Published
30 Jul 2026 02:34
Source
TradingKey
TradingKey Direct company coverage

Compugen Ltd (CGEN) - Tradingkey

This TradingKey stock analysis provides a comprehensive score for Compugen Ltd (CGEN), highlighting its healthy fundamentals, growth potential, and fair valuation within the Biotechnology & Medical Research industry. The company has growing revenue, institutional buying, and mult

Tone
Positive 63/100
Event
Earnings
Published
29 Jul 2026 09:11
Source
TradingKey
TradingKey Direct company coverage

Compugen Ltd (CGEN) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Compugen Ltd (CGEN), detailing various financial metrics related to volatility, financial risk, and investment risk. It presents key data such as the stock's Beta, VaR, maximum drawdown, and Sharpe Ratio over different periods. The repo

Tone
Negative 39/100
Event
Market update
Published
28 Jul 2026 06:09
Source
TradingKey
TradingKey Direct company coverage

CGEN|Compugen Ltd|Price:2.365|Chg%:+0.085

This article provides a detailed company profile for Compugen Ltd (CGEN), a therapeutic discovery company focusing on immuno-oncology programs. It includes information on the company's business scope, financial data, and market performance, along with a list of key executives and

Tone
Neutral 50/100
Event
Market update
Published
27 Jul 2026 15:41
Source
TradingKey